Kee Woo-sung is the Vice Chairman and CEO of Celltrion.
He is expected to join the integrated Celltrion as an internal director along with Seo Jung-jin, Chairman of the Celltrion Group.
He is focused on expanding Celltrion's main business of biosimilars (biopharmaceutical generic drugs) and enhancing new drug development capabilities.
He was born on December 10, 1961 (Lunar Calendar).
After graduating from Joongdong High School in Seoul and Hanyang University's Industrial Engineering Department, he began his career in the Planning Department of Daewoo Motors.
He joined Nexol, the predecessor of Celltrion, when Seo Jung-jin, Honorary Chairman of Celltrion, founded it, and he served as Head of Production Management, Chief Secretary, and Vice President.
He was promoted to Senior Vice President, President, and then co-CEO of Celltrion before being promoted to Vice Chairman in 2018.
He is one of the closest aides to Honorary Chairman Seo Jung-jin.
While serving as Head of Product Development at Celltrion, he developed 'Remsima,' a treatment for autoimmune diseases, laying the foundation for Celltrion.
He has a strong spirit of challenge and values leadership that inspires passion in employees.
#KeeWooSung #Celltrion #biosimilars #biopharmaceuticals #newdrugdevelopment #leadership #pharmaceuticalindustry #SeoJungJin #Remsima #careerpath